Inhibitory Activity of Flavonoids against Class I Phosphatidylinositol 3-Kinase Isoforms

Class I PI3 Kinase (PI3K) phosphorylates phosphatidylinositol 4,5-bisphophate (PIP2) to generate the second messenger phosphatidylinositol 3,4,5-trisphosphate (PIP3) and therefore plays an important role in fundamental cellular responses such as proliferation. There are four isoforms of class I PI3K which are known to have different functions and relate to various diseases such as cancer and inflammation. Flavonoids are abundant in fruits, vegetables and plant-derived beverages such as tea. So far, various pharmacological effects of flavonoids have been reported. We previously reported that the flavonoid baicalein exhibits potent PI3K-inhibitory activity. Recently we examined the inhibitory activity of eighteen flavonoids against PI3Kα by using an in vitro homogenous time resolved fluorescence (HTRF) kinase assay, and deduced their structure-activity relationships by comparing the activities of the analogues. Our result suggests that the number of hydroxyl groups in the A and B rings might promote the activity, while loss of C2-C3 double bond might reduce the activity. Furthermore, the activity against 4 class I PI3K isoforms of some selected flavonoids was investigated, and the results indicate that the flavonoids seem to exhibit more potent activity on PI3Kα and δ isoforms compared with that on PI3Kβ and γ isoforms.

[1]  Alice T. Loo,et al.  PTEN-deficient cancers depend on PIK3CB , 2008, Proceedings of the National Academy of Sciences.

[2]  Dexin Kong,et al.  Effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor, on DNA-dependent protein kinase. , 2009, Biological & pharmaceutical bulletin.

[3]  K. Kobashi,et al.  Balicalin, the Predominant Flavone Glucuronide of Scutellariae Radix, is Absorbed from the Rat Gastrointestinal Tract as the Aglycone and Restored to its Original Form , 2000, The Journal of pharmacy and pharmacology.

[4]  J. Ptak,et al.  High Frequency of Mutations of the PIK3CA Gene in Human Cancers , 2004, Science.

[5]  D Kromhout,et al.  Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. , 1995, Archives of internal medicine.

[6]  S. Dan,et al.  Inhibition profiles of phosphatidylinositol 3-kinase inhibitors against PI3K superfamily and human cancer cell line panel JFCR39. , 2010, European journal of cancer.

[7]  Gary Box,et al.  The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer . , 2008, Journal of medicinal chemistry.

[8]  S. Hirono,et al.  Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor. , 2006, Journal of the National Cancer Institute.

[9]  C. Kandaswami,et al.  The antitumor activities of flavonoids. , 2005, In vivo.

[10]  Daniela Gabriel,et al.  Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity , 2008, Molecular Cancer Therapeutics.

[11]  A. Toker,et al.  Signalling through the lipid products of phosphoinositide-3-OH kinase , 1997, Nature.

[12]  Dexin Kong,et al.  Advances in development of phosphatidylinositol 3-kinase inhibitors. , 2009, Current medicinal chemistry.

[13]  A. Robertson,et al.  PI 3-kinase p110β: a new target for antithrombotic therapy , 2005, Nature Medicine.

[14]  C. Rommel,et al.  PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? , 2007, Nature reviews. Immunology.

[15]  C. Edwards,et al.  Antioxidant flavonols from fruits, vegetables and beverages: measurements and bioavailability. , 2000, Biological research.

[16]  A. Aro,et al.  Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. , 2001, The Journal of nutrition.

[17]  Dexin Kong,et al.  ZSTK474 is an ATP‐competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms , 2007, Cancer science.

[18]  R. Copeland,et al.  Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. , 2011, Biochemical and biophysical research communications.

[19]  Dexin Kong,et al.  Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor. , 2009, European journal of cancer.

[20]  A. Robertson,et al.  PI 3-kinase p110beta: a new target for antithrombotic therapy. , 2005, Nature medicine.

[21]  Dexin Kong,et al.  Phosphatidylinositol 3‐kinase inhibitors: promising drug candidates for cancer therapy , 2008, Cancer science.

[22]  Dexin Kong,et al.  Discovery of phosphatidylinositol 3-kinase inhibitory compounds from the Screening Committee of Anticancer Drugs (SCADS) library. , 2010, Biological & pharmaceutical bulletin.

[23]  E. Middleton Effect of plant flavonoids on immune and inflammatory cell function. , 1998, Advances in experimental medicine and biology.

[24]  M. R. Peluso Flavonoids Attenuate Cardiovascular Disease, Inhibit Phosphodiesterase, and Modulate Lipid Homeostasis in Adipose Tissue and Liver , 2006, Experimental biology and medicine.